A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...

By Chioma Obinna May & Baker Nigeria Plc has celebrated four years of significant growth, marked by a tripling of revenues with a renewed commitment to ambitious expansion targets of N41 billion this ...

The approval makes chenodiol—already cleared for decades to treat radiolucent gallstones under the brand name Chenodal—the ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Anaheim, Calif. — Medical manufacturers are seeing overall growth in the market as it continues to rebound from high levels of inventory from the COVID-19 pandemic and responds to new drug development ...

SBI Mutual Fund on Friday bought additional shares of pharmaceutical company Alkem Laboratories for Rs 300 crore through an ...

BLCO may be sold in 2025 to service the debt of majority shareholder BHC, and any sale will be at a premium to the current ...

Bluebird bio went public in 2013, raising approximately $116m through its IPO. The company has developed three US Food and Drug Administration (FDA)-approved gene therapy products, including Zynteglo ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

An Indian pharmaceutical company is manufacturing unlicensed, addictive opioids and exporting them illegally to Nigeria and other countries in West Africa, consequently driving a major public health ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...